Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
2015 ◽
Vol 386
(10008)
◽
pp. 2078-2088
◽
Cornelia L Trimble
◽
Matthew P Morrow
◽
Kimberly A Kraynyak
◽
Xuefei Shen
◽
Michael Dallas
◽
...
1997 ◽
Vol 175
(4)
◽
pp. 927-931
◽
Mayumi Nakagawa
◽
Daniel P. Stites
◽
Sepideh Farhat
◽
Jerry R. Sisler
◽
Bernard Moss
◽
...
Peter Hillemanns
◽
Karl Ulrich Petry
◽
Linn Woelber
◽
Gerd Böhmer
◽
Elisabeth Stubsrud
◽
...
Peter Hillemanns
◽
Karl Ulrich Petry
◽
Linn Woelber
◽
Gerd Böhmer
◽
Elisabeth Stubsrud
◽
...
Laurent Humeau
◽
◽
Cornelia Trimble
◽
Matthew Morrow
◽
Xuefei Shen
◽
...
2014 ◽
Vol 12
(1)
◽
pp. 44
◽
Hanna-Mari Koskimaa
◽
Anna E Paaso
◽
Marij JP Welters
◽
Seija E Grénman
◽
Kari J Syrjänen
◽
...
2018 ◽
Vol 108
◽
pp. 6-11
Zeni Wu
◽
Lulu Yu
◽
Xiaoqin Lei
◽
Yu Qin
◽
Xun Zhang
◽
...
Hanna-Mari Koskimaa
◽
Anna Paaso
◽
Marij J. P. Welters
◽
Seija Grénman
◽
Kari Syrjänen
◽
...
2016 ◽
Vol 139
(12)
◽
pp. 2812-2826
◽
Suzanne M. Garland
◽
Jorma Paavonen
◽
Unnop Jaisamrarn
◽
Paulo Naud
◽
Jorge Salmerón
◽
...
2017 ◽
Vol 8
(1)
◽
pp. 58-67
◽
Zahra Vahedpoor
◽
Mehri Jamilian
◽
Fereshteh Bahmani
◽
Esmat Aghadavod
◽
Maryam Karamali
◽
...
Close
Export Citation Format
Close
Share Document
Close